Search
NRX Pharmaceuticals Inc
NRXPAdd to Watchlist
3.150USD
+0.030+0.96%
Close 07-31 16:00（ET）Quotes delayed by 15 min
105.43MMarket Cap
LossP/E TTM
NRX Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of NRX Pharmaceuticals Inc is 6.22, ranking 324 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.01, which is -126.04% below the recent high of 0.78 and -827.47% above the recent low of -27.94.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.